Anatomical study of the Cleveland Clinic continuous-flow total artificial heart in adult and pediatric configurations

  • Kiyotaka Fukamachi
  • Jamshid H. Karimov
  • Nicole A. Byram
  • Gengo Sunagawa
  • Raymond Dessoffy
  • Takuma Miyamoto
  • David J. Horvath
Brief Communication Artificial Heart (Basic)
  • 32 Downloads

Abstract

The purpose of this study was to assess the smallest possible body sizes of patients in whom the Cleveland Clinic continuous-flow total artificial heart for adult (CFTAH) and pediatric configurations (P-CFTAH) can fit. One of the most critical dimensions is the vertebra-to-sternum distance at the junction of the right atrium to the inferior vena cava (V–S distance). Our previous CFTAH anatomical fitting study suggested that the CFTAH would fit patients of V–S distance ≥ 7.5 cm and the P-CFTAH of V–S distance ≥ 5.25 cm (70% of 7.5 cm). To confirm this, we assessed the relationship between body surface area (BSA) and V–S distance in 15 adult patients (BSA 1.86–2.62 m2) and 31 pediatric patients (BSA 0.17–1.80 m2) whose computed tomography scans were available. We found a highly significant correlation between BSA and V–S distance (p < 1.0 × 10−25). It appears that the CFTAH will fit in most patients with BSA ≥ 1.0 m2 (corresponding height of ≥ 130 cm and age of 9 years) and the P-CFTAH in patients with BSA ≥ 0.3 m2 (corresponding height of ≥ 55 cm and age of 1 month). Further anatomical fitting studies are needed to evaluate the two pump models inside human chests to determine the smallest patient size/critical dimensions and device port configurations.

Keywords

Total artificial heart Anatomical fit Pediatric device Body surface area 

Notes

Acknowledgements

This study was supported by Cleveland Clinic internal funding. All authors had freedom of investigation and full control of the design of the study, methods used, outcome parameters and results, analysis of data, and production of the written report.

Author contributions

KF: study design, data analysis, supervision, drafting the manuscript, and principal investigator. JHK, NB, GS, and TM: study design and data analysis. DJH: device inventor.

Compliance with ethical standards

Conflict of interest

David J. Horvath is an inventor of the adult continuous-flow total artificial heart. The technology was licensed to Cleveland Heart, Inc., a Cleveland Clinic spin-off company. If the total artificial heart is successful, the inventors and Cleveland Clinic may benefit. None of the other authors has a financial interest or other potential conflict of interest related to the subject matter or materials mentioned in the manuscript.

References

  1. 1.
    Gilboa SM, Salemi JL, Nembhard WN, Fixler DE, Correa A. Mortality resulting from congenital heart disease among children and adults in the United States, 1999–2006. Circulation. 2010;122:2254–63.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Fukamachi K, Horvath DJ, Massiello AL, Fumoto H, Horai T, Rao S, Golding LA. An innovative, sensorless, pulsatile, continuous-flow total artificial heart: device design and initial in vitro study. J Heart Lung Transpl. 2010;29:13–20.CrossRefGoogle Scholar
  3. 3.
    Karimov JH, Moazami N, Kobayashi M, Sale S, Such K, Byram N, Sunagawa G, Horvath D, Gao S, Kuban B, Golding LA, Fukamachi K. First report of 90-day support of 2 calves with a continuous-flow total artificial heart. J Thorac Cardiovasc Surg. 2015;150:687–93.e1.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Karimov JH, Moazami N, Sunagawa G, Kobayashi M, Byram N, Sale S, Such KA, Horvath DJ, Golding LA, Fukamachi K. Median sternotomy or right thoracotomy techniques for total artificial heart implantation in calves. Artif Organs. 2016;40:1022–7.CrossRefPubMedGoogle Scholar
  5. 5.
    Karimov JH, Steffen RJ, Byram N, Sunagawa G, Horvath D, Cruz V, Golding LA, Fukamachi K, Moazami N. Human fitting studies of Cleveland Clinic continuous-flow total artificial heart. ASAIO J. 2015;61:424–8.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Kobayashi M, Horvath DJ, Mielke N, Shiose A, Kuban B, Goodin M, Fukamachi K, Golding LA. Progress on the design and development of the continuous-flow total artificial heart. Artif Organs. 2012;36:705–13.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Fukamachi K, Karimov JH, Horvath DJ, Sunagawa G, Byram NA, Kuban BD, Moazami N. Initial in vitro testing of a paediatric continuous-flow total artificial heart. Interact CardioVasc Thorac Surg. 2018.  https://doi.org/10.1093/icvts/ivx429.
  8. 8.
    Shiose A, Nowak K, Horvath DJ, Massiello AL, Golding LA, Fukamachi K. Speed modulation of the continuous-flow total artificial heart to simulate a physiologic arterial pressure waveform. ASAIO J. 2010;56:403–9.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Kirklin JK. Advances in mechanical assist devices and artificial hearts for children. Curr Opin Pediatr. 2015;27:597–603.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society for Artificial Organs 2018

Authors and Affiliations

  1. 1.Department of Biomedical Engineering/ND20Lerner Research Institute, Cleveland ClinicClevelandUSA
  2. 2.R1 EngineeringEuclidUSA

Personalised recommendations